Insider · CIK 0001823563

Chambers Rebecca

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001823563

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-04	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−2,477 sh	$42.81	−$106K	167,200
2026-09-04	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−1,175 sh	$43.71	−$51.4K	166,025
2026-09-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,603 sh	$44.88	−$162K	169,677
2026-06-04	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−1,600 sh	$49.28	−$78.9K	175,241
2026-06-04	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−1,961 sh	$50.09	−$98.2K	173,280
2026-06-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,693 sh	$47.80	−$177K	176,841
2026-04-20	ALMRAlamar Biosciences, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	−141K sh	—	—	0
2026-04-20	ALMRAlamar Biosciences, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	+141K sh	—	—	140,612
2026-03-06	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+36.2K sh	—	—	167,377
2026-03-06	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+13.2K sh	—	—	180,534
2026-03-04	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−4,400 sh	$35.55	−$156K	145,137
2026-03-04	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−13.9K sh	$36.33	−$506K	131,196
2026-03-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−7,234 sh	$36.01	−$260K	149,537
2026-02-26	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+59.3K sh	—	—	168,820
2026-02-26	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−12K sh	$38.75	−$467K	156,771
2025-12-04	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−8,537 sh	$46.61	−$398K	114,237
2025-12-04	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−4,741 sh	$47.25	−$224K	109,496
2025-12-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,384 sh	$46.16	−$156K	122,774
2025-11-05	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−7,000 sh	$41.00	−$287K	126,158
2025-09-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,371 sh	$30.11	−$162K	133,158
2025-06-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,370 sh	$26.74	−$144K	138,529
2025-03-06	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+30.2K sh	—	—	143,899
2025-03-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−11.1K sh	$34.76	−$385K	113,699
2025-02-27	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+23.2K sh	—	—	136,680
2025-02-27	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−11.9K sh	$33.84	−$403K	124,769
2025-02-19	Inari Medical, Inc.U Disposition from Tender	Director	UDisposition from Tender	−9,684 sh	—	—	0
2025-02-03	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−527 sh	$43.85	−$23.1K	113,510
2024-12-03	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−7,000 sh	$43.23	−$303K	114,037
2024-12-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,464 sh	$44.12	−$153K	121,037
2024-11-12	VCYTVERACYTE, INC.S Sale	Chief Financial Officer	SSale	−15.3K sh	$38.34	−$586K	124,501
2024-09-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,464 sh	$31.55	−$109K	139,776
2024-06-21	Inari Medical, Inc.S Sale	Director	SSale	−260 sh	$45.99	−$12K	9,684
2024-06-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,462 sh	$20.75	−$71.8K	143,240
2024-05-20	Inari Medical, Inc.S Sale	Director	SSale	−964 sh	$45.39	−$43.8K	9,944
2024-04-24	Inari Medical, Inc.A Award	Director	AAward	+4,126 sh	$42.41	+$175K	10,908
2024-03-15	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+4,318 sh	—	—	148,891
2024-03-15	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,189 sh	$21.10	−$46.2K	146,702
2024-03-06	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+59.9K sh	—	—	144,573
2024-03-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−6,112 sh	$24.00	−$147K	84,717
2023-12-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,800 sh	$26.54	−$47.8K	90,829
2023-09-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,652 sh	$26.70	−$97.5K	92,629
2023-06-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,183 sh	$26.72	−$31.6K	95,754
2023-05-18	Inari Medical, Inc.A Award	Director	AAward	+2,412 sh	—	—	6,782
2023-03-06	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+26K sh	—	—	96,937
2023-03-06	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+43K sh	—	—	42,956
2023-03-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,726 sh	$24.10	−$65.7K	70,923
2022-12-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−735 sh	$29.14	−$21.4K	72,998
2022-09-02	VCYTVERACYTE, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,023 sh	$19.18	−$58K	73,733
2022-08-05	VCYTVERACYTE, INC.A Award	Chief Financial Officer	AAward	+21.4K sh	—	—	76,756
2022-08-05	VCYTVERACYTE, INC. · Common StockA Award	Chief Financial Officer	AAward	+36.5K sh	—	—	36,496

Recent filings

Accepted (ET)
Sep 44
Chambers Rebecca0001823563-26-000016
SEC(opens sec.gov)
Jun 44
Chambers Rebecca0001823563-26-000014
SEC(opens sec.gov)
Apr 204
Chambers Rebecca0001823563-26-000013
SEC(opens sec.gov)
Mar 104
Chambers Rebecca0001823563-26-000008
SEC(opens sec.gov)
Mar 64
Chambers Rebecca0001823563-26-000006
SEC(opens sec.gov)
Mar 44
Chambers Rebecca0001823563-26-000004
SEC(opens sec.gov)
Mar 24
Chambers Rebecca0001823563-26-000002
SEC(opens sec.gov)
Dec 44
Chambers Rebecca0001823563-25-000007
SEC(opens sec.gov)
Nov 74
Chambers Rebecca0001823563-25-000005
SEC(opens sec.gov)
Sep 44
Chambers Rebecca0001384101-25-000122
SEC(opens sec.gov)

Companies

Address

6000 SHORELINE COURT SUITE 300

SOUTH SAN FRANCISCO, CA, 94080